SOMLY Quote, Financials, Valuation and Earnings

Kubota has a net margin of 9.53% compared to SECOM's net margin of 6.75%. SECOM's return on equity of 7.56% beat Kubota's return on equity of 9.86%.

SECOM has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 30.35%. Given that Kubota has higher upside potential than SECOM, analysts believe Kubota is more attractive than SECOM.

SECOM has a beta of 0.351, which suggesting that the stock is 64.883% less volatile than S&P 500. In comparison Kubota has a beta of 0.963, suggesting its less volatile than the S&P 500 by 3.749%.

SECOM has a quarterly dividend of $0.08 per share corresponding to a yield of 1.75%. Kubota offers a yield of 2.64% to investors and pays a quarterly dividend of $0.82 per share. SECOM pays 39.71% of its earnings as a dividend. Kubota pays out 24.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SECOM quarterly revenues are $2B, which are smaller than Kubota quarterly revenues of $4.7B. SECOM's net income of $190.3M is lower than Kubota's net income of $317.2M. Notably, SECOM's price-to-earnings ratio is 20.87x while Kubota's PE ratio is 8.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SECOM is 2.74x versus 0.73x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of 9.53% compared to SECOM's net margin of -3.6%. SECOM's return on equity of 7.56% beat Kyocera's return on equity of 1.45%.

SECOM has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of $11.40 which suggests that it could fall by --. Given that Kyocera has higher upside potential than SECOM, analysts believe Kyocera is more attractive than SECOM.

SECOM has a beta of 0.351, which suggesting that the stock is 64.883% less volatile than S&P 500. In comparison Kyocera has a beta of 0.241, suggesting its less volatile than the S&P 500 by 75.921%.

SECOM has a quarterly dividend of $0.08 per share corresponding to a yield of 1.75%. Kyocera offers a yield of 2.82% to investors and pays a quarterly dividend of $0.17 per share. SECOM pays 39.71% of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SECOM quarterly revenues are $2B, which are smaller than Kyocera quarterly revenues of $3.2B. SECOM's net income of $190.3M is higher than Kyocera's net income of -$116.4M. Notably, SECOM's price-to-earnings ratio is 20.87x while Kyocera's PE ratio is 50.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SECOM is 2.74x versus 1.18x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of 9.53% compared to SECOM's net margin of 5.34%. SECOM's return on equity of 7.56% beat SBC Medical Group Holdings's return on equity of 25.89%.

SECOM has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 207.69%. Given that SBC Medical Group Holdings has higher upside potential than SECOM, analysts believe SBC Medical Group Holdings is more attractive than SECOM.

SECOM has a beta of 0.351, which suggesting that the stock is 64.883% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

SECOM has a quarterly dividend of $0.08 per share corresponding to a yield of 1.75%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SECOM pays 39.71% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. SECOM's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SECOM quarterly revenues are $2B, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. SECOM's net income of $190.3M is higher than SBC Medical Group Holdings's net income of $2.8M. Notably, SECOM's price-to-earnings ratio is 20.87x while SBC Medical Group Holdings's PE ratio is 7.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SECOM is 2.74x versus 1.50x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.

THK has a net margin of 9.53% compared to SECOM's net margin of 2.32%. SECOM's return on equity of 7.56% beat THK's return on equity of 3.53%.

SECOM has a consensus price target of --, signalling downside risk potential of --. On the other hand THK has an analysts' consensus of -- which suggests that it could fall by --. Given that SECOM has higher upside potential than THK, analysts believe SECOM is more attractive than THK.

SECOM has a beta of 0.351, which suggesting that the stock is 64.883% less volatile than S&P 500. In comparison THK has a beta of 0.865, suggesting its less volatile than the S&P 500 by 13.478%.

SECOM has a quarterly dividend of $0.08 per share corresponding to a yield of 1.75%. THK offers a yield of 0.93% to investors and pays a quarterly dividend of $0.06 per share. SECOM pays 39.71% of its earnings as a dividend. THK pays out 39.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SECOM quarterly revenues are $2B, which are larger than THK quarterly revenues of $574.1M. SECOM's net income of $190.3M is higher than THK's net income of $13.3M. Notably, SECOM's price-to-earnings ratio is 20.87x while THK's PE ratio is 35.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SECOM is 2.74x versus 1.33x for THK. Usually stocks with elevated PS ratios are considered overvalued.